A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 17, 1998, Pages 10176-10181

  Mets, Berend ^a   Winger, Gail ^b   Cabrera, Camilo ^b   Seo, Susan ^a   Jamdar, Subhash ^a   Yang, Ginger ^a   Zhao, Kang ^a   Briscoe, Richard J ^b   Almonte, Rowena ^a   Woods, James H ^b,c   Landry, Donald W ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBOXYLESTERASE; COCAINE; DRUG ANTIBODY; ECGONINE METHYL ESTER; MONOCLONAL ANTIBODY 15 A 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG OVERDOSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SUBSTANCE ABUSE; SUDDEN DEATH;

ANIMALS; ANTIBODIES, CATALYTIC; ANTIBODIES, MONOCLONAL; COCAINE; DISEASE MODELS, ANIMAL; HYDROLYSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 13144283624     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.17.10176     Document Type: Article

References (21)

1. Office of National Drug Control Policy (1996) The National Drug Control Strategy (Executive Office of the President of the United States, Washington, D.C.), pp. 41-51.
2. Johanson, C. E. & Fischman, M. W. (1989) Pharmacol. Rev. 41, 3-52.
3. Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. (1987) Science 237, 1219-1223.
4. Winger, G. (1998) in Cocaine Abuse Research: Pharmacology, Behavior, and Clinical Applications, eds. Higgins, S. T. & Katz, J. L. (Academic, New York).
5. Ritz, M. C. & George, F. R. (1993) J. Pharmacol. Exp. Ther. 264, 1333-1343.
6. Schechter, M. D. & Meehan, S. M. (1995) Pharmacol. Biochem. Behav. 51, 521-523.
7. Gantenberg, N. S. & Hageman, G. R. (1992) Can. J. Physiol. Pharmacol. 70, 240-246.
8. Bonese, K. F., Wainer, B. H., Fitch, F. W., Rothberg, R. M. & Schuster, C. R. (1974) Nature (London) 252, 708-710.
9. Lerner, R. A., Benkovic, S. J. & Schultz, P. G. (1991) Science 252, 659-667.
10. Misra, A. L., Nayak, P. K., Bloch, R. & Mule, S. J. (1975) J. Pharm. Pharmacol. 27, 784-786.
11. Landry, D. W., Zhao, K., Yang, G. X., Glickman, M. & Georgiadis, T. M. (1993) Science 259, 1899-1901.
12. Yang, G., Chun, J., Arakawa-Uramoto, H., Wang, X., Gawinowicz, M. A. Zhao, Z. & Landry, D. W. (1996) J. Am. Chem. Soc. 118, 5881-5890.
13. Kubota, K. & Ishizaki, T. (1991) Eur. J. Clin. Pharmacol. 41, 363-368.
14. Mets, B., Jamdar, S. & Landry, D. (1996) Life Sci. 59, 2021-2031.
15. Pudiak, C. M. & Bozarth, M. A. (1994) Life Sci. 55, PL379-PL382.
16. Stratton, S. J., Rogers, C. & Green, K. (1995) Ann. Emerg. Med. 25, 710-712.
17. Virag, L., Mets, B. & Jamdar, S. (1996) J. Chromatogr. 681, 263-269.
18. Yoburn, B. C., Morales, R. & Inturrisi, C. E. (1984) Physiol. Behav. 33, 89-94.
19. Hoffman, R. S., Morasco, R. & Goldfrank, L. R. (1996) J. Toxicol. Clin. Toxicol. 34, 259-266.
20. Carrera, M. R., Ashley, J. A., Parson, L. H., Wirsching, P., Koob, G. F. & Janda, K. D. (1995) Nature (London) 378, 666-667.
21. Fox, B. S., Kantak, K. M., Edwards, M. A., Black, K. M., Bollinger, B. K., Botka, A. J., French, T. L., Thompson, T. L., Schad, V. C., Greenstein, J. L., et al. (1996) Nat. Med. 2, 1129-1132.